Zhao Xiaoying,Wang Chen Chen,Zhang Wen,Zhu Xiaodong,&Chen Zhi-Yu.(2017).Preliminary analysis of FOLFIRI regimen with or without bevacizumab as second-line systemic therapy in patients with metastatic gastroenteropancreatic neuroendocrine carcinoma. .JOURNAL OF CLINICAL ONCOLOGY,35(4).